MRI Planimetry and Magnetic Resonance Parkinsonism Index in the Differential Diagnosis of Patients with Parkinsonism

REFERENCES

1. 1.↵
   2. Rolland Y,
   3. Vérin M,
   4. Payan C, et al

   ; NNIPPS Study Group. A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. J Neurol Neurosurg Psychiatry 2011;82:1025–32 doi:10.1136/jnnp.2010.214890 pmid:21386111

   Abstract/FREE Full Text
2. 2.↵
   2. Respondek G,
   3. Roeber S,
   4. Kretzschmar H, et al

   . Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Mov Disord 2013;28:504–09 doi:10.1002/mds.25327 pmid:23436751

   CrossRefPubMed
3. 3.↵
   2. Osaki Y,
   3. Ben-Shlomo Y,
   4. Lees AJ, et al

   . A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord 2009;24:2272–76 doi:10.1002/mds.22826 pmid:19845011

   CrossRefPubMed
4. 4.↵
   2. Armstrong MJ,
   3. Litvan I,
   4. Lang AE, et al

   . Criteria for the diagnosis of corticobasal degeneration. Neurology 2013;80:496–503 doi:10.1212/WNL.0b013e31827f0fd1 pmid:23359374

   Abstract/FREE Full Text
5. 5.↵
   2. Hauw JJ,
   3. Daniel SE,
   4. Dickson D, et al

   . Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015–19 doi:10.1212/WNL.44.11.2015 pmid:7969952

   Abstract/FREE Full Text
6. 6.↵
   2. Yamauchi H,
   3. Fukuyama H,
   4. Nagahama Y, et al

   . Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy. Ann Neurol 1997;41:606–14 doi:10.1002/ana.410410509 pmid:9153522

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Wenning GK,
   3. Tison F,
   4. Ben Shlomo Y, et al

   . Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133–47 doi:10.1002/mds.870120203 pmid:9087971

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Dickson DW,
   3. Bergeron C,
   4. Chin SS, et al

   ; Office of Rare Diseases of the National Institutes of Health. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935–46 doi:10.1093/jnen/61.11.935 pmid:12430710

   CrossRefPubMed
9. 9.↵
   2. Yamauchi H,
   3. Fukuyama H,
   4. Nagahama Y, et al

   . Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration. Arch Neurol 1998;55:609–14 doi:10.1001/archneur.55.5.609 pmid:9605717

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Quattrone A,
    3. Nicoletti G,
    4. Messina D, et al

    . MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008;246:214–21 doi:10.1148/radiol.2453061703 pmid:17991785

    CrossRefPubMed
11. 11.↵
    2. Litvan I,
    3. Agid Y,
    4. Calne D, et al

    . Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1–9 doi:10.1212/WNL.47.1.1 pmid:8710059

    Abstract/FREE Full Text
12. 12.↵
    2. Gilman S,
    3. Wenning GK,
    4. Low PA, et al

    . Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670–76 doi:10.1212/01.wnl.0000324625.00404.15 pmid:18725592

    Abstract/FREE Full Text
13. 13.↵
    2. Paraskevas GP,
    3. Kasselimis D,
    4. Kourtidou E, et al

    . Cerebrospinal fluid biomarkers as a diagnostic tool of the underlying pathology of primary progressive aphasia. J Alzheimers Dis 2017;55:1453–61 doi:10.3233/JAD-160494 pmid:27858708

    CrossRefPubMed
14. 14.↵
    2. Hughes AJ,
    3. Daniel SE,
    4. Kilford L, et al

    . Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181–84 doi:10.1136/jnnp.55.3.181 pmid:1564476

    Abstract/FREE Full Text
15. 15.↵
    2. Kato N,
    3. Arai K,
    4. Hattori T

    . Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 2003;210:57–60 doi:10.1016/S0022-510X(03)00014-5 pmid:12736089

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Longoni G,
    3. Agosta F,
    4. Kostić VS, et al

    . MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease. Mov Disord 2011;26:247–55 doi:10.1002/mds.23293 pmid:21412831

    CrossRefPubMed
17. 17.↵
    2. Cosottini M,
    3. Ceravolo R,
    4. Faggioni L, et al

    . Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 2007;116:37–42 doi:10.1111/j.1600-0404.2006.00767.x pmid:17587253

    CrossRefPubMed
18. 18.↵
    2. Morelli M,
    3. Arabia G,
    4. Salsone M, et al

    . Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease. Mov Disord 2011;26:527–33 doi:10.1002/mds.23529 pmid:21287599

    CrossRefPubMed
19. 19.↵
    2. Hofer S,
    3. Frahm J

    . Topography of the human corpus callosum revisited; comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. Neuroimage 2006;32:989–94 doi:10.1016/j.neuroimage.2006.05.044 pmid:16854598

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Fazekas F,
    3. Chawluk JB,
    4. Alavi A

    . MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;8:421–26 doi:10.2214/ajr.149.2.351 pmid:3496763

    CrossRefPubMed
21. 21.↵
    2. Aiba I,
    3. Hashizume Y,
    4. Yoshida M, et al

    . Relationship between brainstem MRI and pathological findings in progressive supranuclear palsy: study in autopsy cases. J Neurol Sci 1997;152:210–17 doi:10.1016/S0022-510X(97)00166-4 pmid:9415543

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Slowinski J,
    3. Imamura A,
    4. Uitti RJ, et al

    . MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 2008;255:37–44 doi:10.1007/s00415-007-0656-y pmid:18080856

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Hussl A,
    3. Mahlknecht P,
    4. Scherfler C

    . Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy. Mov Disord 2010;25:2444–49 doi:10.1002/mds.23351 pmid:20878992

    CrossRefPubMed
24. 24.↵
    2. Kim YH,
    3. Ma HI,
    4. Kim YJ

    . Utility of the midbrain tegmentum diameter in the differential diagnosis of progressive supranuclear palsy from idiopathic Parkinson's disease. J Clin Neurol 2015;11:268–74 doi:10.3988/jcn.2015.11.3.268 pmid:26174787

    CrossRefPubMed
25. 25.↵
    2. Morelli M,
    3. Arabia G,
    4. Novellino F, et al

    . MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study. Neurology 2011;77:1042–47 doi:10.1212/WNL.0b013e31822e55d0 pmid:21832222

    Abstract/FREE Full Text
26. 26.↵
    2. Massey LA,
    3. Jäger HR,
    4. Paviour DC, et al

    . The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology 2013;80:1856–61 doi:10.1212/WNL.0b013e318292a2d2 pmid:23616165

    Abstract/FREE Full Text
27. 27.↵
    2. Kaasinen V,
    3. Kangassalo N,
    4. Gardberg M, et al

    . Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort. Neurol Sci 2015;36:1251–53 doi:10.1007/s10072-015-2184-3 pmid:25805708

    CrossRefPubMed
28. 28.↵
    2. Oba H,
    3. Yagishita A,
    4. Terada H, et al

    . New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005;64:2050–55 doi:10.1212/01.WNL.0000165960.04422.D0 pmid:15985570

    Abstract/FREE Full Text
29. 29.↵
    2. Gröschel K,
    3. Hauser T-K,
    4. Luft A, et al

    . Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage 2004;21:714–24 doi:10.1016/j.neuroimage.2003.09.070 pmid:14980574

    CrossRefPubMedWeb of Science